1 Start 2 Complete
*
*
ExcellentSatisfactoryPoor
Overall, how would you rate this series?
*
OutstandingGoodSatisfactoryFairPoor
Assess the Myeloproliferative Neoplasms (MPN) disease severity.
Outline treatment options for patients with Myeloproliferative Neoplasms (MPN) disease.
Enroll patients in clinical trials for (MPN).
Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
*
YesNo
Objective
Fair & Balanced
Free of Commercial Bias